𝐊𝐞𝐧𝐲𝐚 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬 𝐋𝐨𝐧𝐠-𝐀𝐜𝐭𝐢𝐧𝐠 𝐇𝐈𝐕 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐈𝐧𝐣𝐞𝐜𝐭𝐢𝐨𝐧

Kenya has officially launched Lenacapavir, a ground-breaking long-acting injectable for HIV prevention, in a major step to curb new infections and strengthen the national HIV response. The launch was presided over by Cabinet Secretary for Health Hon. Aden Duale at Riruta Health Centre in Nairobi.
The Cabinet Secretary described the introduction of Lenacapavir as a milestone in prevention efforts, noting that 1.4 million Kenyans are living with HIV, with thousands of new infections recorded each year.

He emphasised that expanding innovative prevention options is critical to reversing transmission trends and protecting vulnerable populations.
The injectable will be administered twice a year and offered free of charge to eligible individuals at selected public health facilities in priority counties.

In a related development, Lesotho’s Minister of Health, Selibe Mochoboroane, is expected to receive the Lenacapavir injection at the National Drug Service Organisation (NDSO) in Mafeteng later today, signalling growing regional momentum behind the new prevention strategy.